“…The probes used for the test covered HPV types 16,18,31,33,35,39,45,51,52,56,58,59, and 68. Colposcopically directed cervical biopsy confirmed SCC in situ.…”
Squamous cell carcinoma (SCC) of the fallopian tube is rare and often diagnosed postoperatively. Cervical cancer is considered as a long-term sequaele, resulting from sexual transmitted infection with certain common high-risk human papilloma virus (HPV) types. The role of human papilloma virus in the development of the tubal SCC is unknown. We report an unusual case of SCC of the fallopian tube, synchronously occurring with cervical SCC in situ in a 49-year-old patient. Histological examination of the entire endometrium revealed no involvement Both tubal and cervical lesions showed the presence of high risk HPV 16 by PCR and increased expression of p16(INK4a) protein. Both SCC of the fallopian tube and cervical SCC in situ were positive for p63, while the non-involved tubal epithelium was positive for WT-1, but negative for p63. In conclusion, the concomitant occurrence of fallopian tube and cervical SCC can be explained by: (i) the 'field effect' of HPV infection resulting in the concomitant development of primary SCC in various sites of the female genital tract; (ii) the primary fallopian tube SSC metastasizing to the uterine cervix; or (iii) primary cervical SCC metastasizing to the fallopian tube. The detection of HPV 16 and p16(INK4a) in both the fallopian tube and cervicalSCCs strengthens the hypothesis of the 'field effect' of HPV infection.
“…The probes used for the test covered HPV types 16,18,31,33,35,39,45,51,52,56,58,59, and 68. Colposcopically directed cervical biopsy confirmed SCC in situ.…”
Squamous cell carcinoma (SCC) of the fallopian tube is rare and often diagnosed postoperatively. Cervical cancer is considered as a long-term sequaele, resulting from sexual transmitted infection with certain common high-risk human papilloma virus (HPV) types. The role of human papilloma virus in the development of the tubal SCC is unknown. We report an unusual case of SCC of the fallopian tube, synchronously occurring with cervical SCC in situ in a 49-year-old patient. Histological examination of the entire endometrium revealed no involvement Both tubal and cervical lesions showed the presence of high risk HPV 16 by PCR and increased expression of p16(INK4a) protein. Both SCC of the fallopian tube and cervical SCC in situ were positive for p63, while the non-involved tubal epithelium was positive for WT-1, but negative for p63. In conclusion, the concomitant occurrence of fallopian tube and cervical SCC can be explained by: (i) the 'field effect' of HPV infection resulting in the concomitant development of primary SCC in various sites of the female genital tract; (ii) the primary fallopian tube SSC metastasizing to the uterine cervix; or (iii) primary cervical SCC metastasizing to the fallopian tube. The detection of HPV 16 and p16(INK4a) in both the fallopian tube and cervicalSCCs strengthens the hypothesis of the 'field effect' of HPV infection.
“…Nevertheless, the view that these are metastatic has been challenged and discussed in the literature, the alternative being that the neoplastic change in the ovary occurs as a part of a field change to a common oncogenic insult. It is postulated that this may be facilitated by transtubal transfer of HPV‐infected or transformed cells and disruption of the ovarian surface due to ovulatory injury in women in their reproductive years 71 . The relatively good outcome and indolent course of cases with minimally invasive endocervical primaries with isolated ovarian involvement documented 67 lends some credence to this view.…”
Section: Synchronous Cervical and Ovarian Neoplasmsmentioning
confidence: 99%
“…It is postulated that this may be facilitated by transtubal transfer of HPVinfected or transformed cells and disruption of the ovarian surface due to ovulatory injury in women in their reproductive years. 71 The relatively good outcome and indolent course of cases with minimally invasive endocervical primaries with isolated ovarian involvement documented 67 lends some credence to this view. It is possible that more detailed clonal analysis will be able to elucidate the exact relationship between such tumours in the future.…”
Section: Synchronous Cervical and Ovarian Neoplasmsmentioning
About 1-2% of women with gynaecological cancers are found to have two or more simultaneous independent primary malignancies. Low stage multiple primaries must be distinguished from metastasis from one to other site for correct management. Synchronous tumours in the ovary and endometrium are the commonest combination. Most of these can be accurately categorised by standard histological criteria. Molecular testing has been advocated for valuable adjunctive information in ambiguous cases but must be interpreted with clinicopathological correlation: loss of heterozygosity, pTEN or beta-catenin gene mutational analysis, microsatellite instability and most recently gene expression profiling have all been used. The pattern of beta-catenin immunohistochemical expression has been reported to be of value. A very low percentage of women with synchronous primaries in the uterus and ovary are HNPCC patients and testing for mismatch repair gene mutations is unnecessary in all cases, even if young; the diagnosis of HNPCC should be based on standard criteria. Women with endometrial cancer under 50 are more likely than older patients to have a synchronous ovarian cancer. Rarer combinations of synchronous tumours are less well studied but may also represent a mixture of unusual patterns of metastasis and multifocal origin; these are discussed briefly.
“…In the Ronnett series, 17 of 19 patients who underwent lymphadenectomy had no lymph nodal metastasis, and of the 18 cases with available follow-up, 14 patients were alive with no evidence of disease (10-83 months' follow-up period) and two others were alive with disease. Due to these unusual pathological features and apparently favourable clinical outcome, the possibility that this represents an example of an independent ovarian neoplasm as a result of a 'field effect' of oncogenic HPV has also been suggested (Reichert, 2005a) though refuted (Reichert, 2005b). This case identifies the importance of follow up for women previously treated for an early cervical cancer.…”
► Post cervical cancer treatment new pelvic abnormality must be regarded as recurrence. ► Benign MRI features does not exclude recurrence from previous cervical adenocarcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.